Efficacy News and Research

RSS

Vaccination lowers the risk of experiencing severe COVID-19 in dialysis patients

In an analysis of patients with kidney failure receiving dialysis who had become infected with SARS-CoV-2, those who were vaccinated had a lower risk of experiencing severe COVID-19.

3 Jun 2022

Marine organism compounds may have potential to help human fertility

Zinc-filled oysters are often linked to improved libido and sexual activity, and now scientists at Flinders University are calling for more serious investigations into how marine organism compounds can help human fertility.

3 Jun 2022

Vaccine-induced immunity against severe COVID-19 remains high for about six months

Protection against symptomatic COVID-19 begins to decrease after one month from initial vaccination, while immunity against severe COVID-19 remains high for about six months, according to a recent study by Penn State College of Medicine scientists.

2 Jun 2022

COVID-19 superspreader events typically originate from few carriers

A recent research paper published in the journal Physics of Fluids analyzed the overdispersion in the coronavirus disease 2019 (COVID-19) airborne transmission.

2 Jun 2022

Benefits and limitations of non-invasive tests for diagnosing non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent chronic liver disorders worldwide and can sometimes lead to severe conditions like cirrhosis and hepatocellular carcinoma.

2 Jun 2022

Black youth in racist communities less likely to benefit from psychotherapy

A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that Black youth living in communities with high (vs. low) anti-Black racism are less likely to benefit from psychotherapy ("talk therapy;" such as cognitive behavioral therapy).

2 Jun 2022

Immune modulator drugs improved clinical status, reduced deaths among patients hospitalized with COVID-19

A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept - drugs widely used to treat certain autoimmune diseases - did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths.

2 Jun 2022

Researchers receive $1.1 million to study the safety, efficacy of drug combination for chronic pancreatitis

Researchers from Indiana University School of Medicine are studying the safety and efficacy of a drug combination for patients with chronic pancreatitis (CP).

2 Jun 2022

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Aerobic exercise reprograms the immune system to reduce pancreatic tumor growth and amplify the effects of immunotherapy, a new study finds.

2 Jun 2022

Skirmishes over medication abortions may renew debate on state vs. federal powers

As the Supreme Court appears poised to overturn Roe v. Wade, the landmark decision that guarantees the constitutional right to an abortion, reproductive rights advocates are considering new ways to protect nationwide access to the procedure.

2 Jun 2022

Pneumonia frequency and severity found to be lower in patients with full COVID-19 vaccination

According to ARRS' American Journal of Roentgenology (AJR), evaluating chest CT findings offers an additional approach for demonstrating the efficacy of different COVID-19 vaccines in reducing the impact of a COVID-19 diagnosis.

1 Jun 2022

New "masked" version of immunotherapy could help fight cancer without causing side effects

Many cancer treatments are notoriously savage on the body; they attack healthy cells at the same time as tumor cells, causing a plethora of side effects.

1 Jun 2022

SARS-CoV-2 variant emergence patterns across Alaska

A new study preprint server assesses the pattern of SARS-CoV-2 variant emergence across Alaska.

1 Jun 2022

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

Researchers hypothesized that the emergence of resistant SARS-CoV-2 variants can be anticipated by identifying possible escape mutations already present in the existing SARS-CoV-2 populations.

1 Jun 2022

Study assesses the effectiveness of telemedicine-based pediatric genetics care

A new study from researchers at Children's Hospital of Philadelphia (CHOP) found that using telemedicine to evaluate patients with rare genetic conditions resulted in a similar rate of proper diagnosis as in-person visits.

1 Jun 2022

Liver4Life research team treated damaged liver in a machine and then implanted the recovered organ

The multidisciplinary Zurich research team Liver4Life has succeeded in doing something during a treatment attempt that had never been achieved in the history of medicine until now: it treated an originally damaged human liver in a machine for three days outside a body and then implanted the recovered organ into a cancer patient.

31 May 2022

New androgen biosynthesis inhibitor drug for prostate cancer shows mixed results

A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies, according to a study published in the Journal of Clinical Oncology.

31 May 2022

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

A recent article assessed the potency of tixagevimab/cilgavimab in averting SARS-CoV-2 infection in vaccinated immunocompromised people.

31 May 2022

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

A recent study evaluated the protection conferred by mRNA vaccines and prior infection against the SARS-CoV-2 Omicron variant.

31 May 2022

New digital tool provides effective support for the treatment of pediatric obesity

A mobile app that shows a child's weight development in real-time for children with obesity provides greater weight loss compared to conventional care.

31 May 2022

Efficacy News and Research

Vaccination lowers the risk of experiencing severe COVID-19 in dialysis patients

Marine organism compounds may have potential to help human fertility

Vaccine-induced immunity against severe COVID-19 remains high for about six months

COVID-19 superspreader events typically originate from few carriers

Benefits and limitations of non-invasive tests for diagnosing non-alcoholic fatty liver disease

Black youth in racist communities less likely to benefit from psychotherapy

Immune modulator drugs improved clinical status, reduced deaths among patients hospitalized with COVID-19

Researchers receive $1.1 million to study the safety, efficacy of drug combination for chronic pancreatitis

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Skirmishes over medication abortions may renew debate on state vs. federal powers

Pneumonia frequency and severity found to be lower in patients with full COVID-19 vaccination

New "masked" version of immunotherapy could help fight cancer without causing side effects

SARS-CoV-2 variant emergence patterns across Alaska

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

Study assesses the effectiveness of telemedicine-based pediatric genetics care

Liver4Life research team treated damaged liver in a machine and then implanted the recovered organ

New androgen biosynthesis inhibitor drug for prostate cancer shows mixed results

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

New digital tool provides effective support for the treatment of pediatric obesity

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News